Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
IC7:FRA
ICU Medical Inc
101,00 €
+3,06%
(+3,00) 1D
30 apr, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IC7...
Açın
97,00 €
High
101,00 €
Low
97,00 €
Mkt. cap
2,97 mlrd
Avg. vol.
4,00
Volume
0,00
52-wk high
136,00 €
52-wk low
92,00 €
No. of employees
13K
News stories
From sources across the web
Profile
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
About ICU Medical Inc
CEOVivek Jain
Employees13K
Founded1984
HeadquartersSan Clemente, Kaliforniya, Amerika Birləşmiş Ştatları
SectorMedical device
Websiteicumed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
604,70 mln
548,87 mln
536,99 mln
540,70 mln
Cost of goods sold
394,59 mln
340,80 mln
336,11 mln
337,72 mln
Cost of revenue
394,59 mln
340,80 mln
336,11 mln
337,72 mln
Research and development expenses
23,29 mln
21,87 mln
21,25 mln
21,09 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
157,23 mln
159,39 mln
152,77 mln
155,81 mln
Operating expense
180,52 mln
181,26 mln
174,02 mln
176,90 mln
Total operating expenses
575,12 mln
522,06 mln
510,13 mln
514,62 mln
Operating income
29,58 mln
26,80 mln
26,86 mln
26,09 mln
Other non operating income
209,00K
-68,00K
238,00K
-32,00K
EBT including unusual items
-10,91 mln
36,52 mln
-4,05 mln
-18,39 mln
EBT excluding unusual items
5,96 mln
10,97 mln
7,57 mln
4,75 mln
Income tax expense
4,57 mln
1,18 mln
-658,00K
-2,65 mln
Effective tax rate
-41,90%
3,23%
16,23%
14,43%
Other operating expenses
-
-
-
-
Net income
-15,48 mln
35,34 mln
-3,40 mln
-15,73 mln
Net profit margin
-2,56%
6,44%
-0,63%
-2,91%
Earnings per share
1,72
2,10
2,03
1,91
Interest and investment income
3,23 mln
2,52 mln
2,42 mln
2,14 mln
Interest expense
-25,26 mln
-23,06 mln
-22,23 mln
-22,78 mln
Net interest expenses
-22,03 mln
-20,55 mln
-19,81 mln
-20,64 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
79,03 mln
76,47 mln
77,66 mln
76,92 mln
Gain or loss from assets sale
1,70 mln
-41,77 mln
-1,51 mln
2,69 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer